These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12049681)

  • 1. Effect of the final coronary arterial diameter after coronary angioplasty on heart rate variability responses.
    Kanadasi M; Kudaiberdieva G; Birand A
    Ann Noninvasive Electrocardiol; 2002 Apr; 7(2):106-13. PubMed ID: 12049681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heart rate variability in patients treated with percutaneous transluminal coronary angioplasty].
    Sedziwy E; Olszowska M; Tracz W; Pieniazek P
    Przegl Lek; 2002; 59(9):695-8. PubMed ID: 12632888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent changes of heart rate variability after percutaneous transluminal angioplasty.
    Osterhues HH; Kochs M; Hombach V
    Am Heart J; 1998 May; 135(5 Pt 1):755-61. PubMed ID: 9588404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
    Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of exercise training on heart rate variability after coronary angioplasty.
    Tsai MW; Chie WC; Kuo TB; Chen MF; Liu JP; Chen TT; Wu YT
    Phys Ther; 2006 May; 86(5):626-35. PubMed ID: 16649887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of coronary angioplasty on heart rate variability explored in the domain of time and frequency in patients with one-vessel coronary disease].
    Petretta M; Marciano F; Migaux ML; Salemme L; Themistoclakis S; Esposito N; Carpinelli A; Apicella C; Piscione F; Bonaduce D
    G Ital Cardiol; 1994 Aug; 24(8):973-84. PubMed ID: 7958639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of percutaneous transluminal coronary angioplasty on QT dispersion and heart rate variability parameters.
    Aydinlar A; Sentürk T; Ozdemïr B; Kaderlï AA; Aydin O
    Cardiovasc J Afr; 2009; 20(4):240-4. PubMed ID: 19701536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of heart rate variability parameters and QT interval in patients after PTCA of infarct related coronary artery as an indicator of improved autonomic regulation.
    Szydlo K; Trusz-Gluza M; Drzewiecki J; Wozniak-Skowerska I; Szczogiel J
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2407-10. PubMed ID: 9825357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in heart rate variability caused by coronary angioplasty depend on the localisation of coronary lesions.
    Janowska-Kulińska A; Torzyńska K; Markiewicz-Grochowalska A; Sowińska A; Majewski M; Jerzykowska O; Pawlak-Buś K; Kramer L; Moczko J; Siminiak T
    Kardiol Pol; 2009 Feb; 67(2):130-8; discussion 139. PubMed ID: 19288375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cause-effect relationship of sympathovagal activity and the outcome of percutaneous transluminal coronary angioplasty.
    Tseng CD; Wang TL; Lin JL; Hsu KL; Chiang FT; Tseng YZ
    Jpn Heart J; 1996 Jul; 37(4):455-62. PubMed ID: 8890759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternans of ventricular gradient during percutaneous transluminal coronary angioplasty.
    Horinaka S; Hara S; Tsuchiya N; Yabe A; Asakawa H; Yagi H; Mori Y; Matsuoka H
    J Electrocardiol; 2001 Apr; 34(2):135-9. PubMed ID: 11320461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced heart rate variability in ischemic heart disease is only partially caused by ischemia. An HRV study before and after PTCA.
    Wennerblom B; Lurje L; Solem J; Tygesen H; Udén M; Vahisalo R; Hjalmarson A
    Cardiology; 2000; 94(3):146-51. PubMed ID: 11279319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary vasomotion after percutaneous transluminal coronary angioplasty depends on the severity of the culprit lesion.
    Mandinov L; Kaufmann P; Staub D; Buckingham TA; Amann FW; Hess OM
    J Am Coll Cardiol; 1997 Sep; 30(3):682-8. PubMed ID: 9283526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of regional myocardial perfusion following percutaneous transluminal coronary angioplasty in patients with coronary artery disease.
    Kanemoto N; Hör G
    Jpn Heart J; 1985 Jul; 26(4):495-508. PubMed ID: 2932566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate variability in patients with acute myocardial infarction undergoing primary coronary angioplasty.
    Bonnemeier H; Hartmann F; Wiegand UK; Irmer C; Kurz T; Tölg R; Katus HA; Richardt G
    Am J Cardiol; 2000 Apr; 85(7):815-20. PubMed ID: 10758919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early decrease in minimal luminal diameter after successful percutaneous transluminal coronary angioplasty predicts late restenosis.
    Rodriguez A; Santaera O; Larribeau M; Sosa MI; Palacios IF
    Am J Cardiol; 1993 Jun; 71(16):1391-5. PubMed ID: 8517382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty.
    Birand A; Kudaiberdieva GZ; Batyraliev TA; Akgul F; Usal A
    Angiology; 1997 May; 48(5):413-22. PubMed ID: 9158385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty.
    Herrmann HC; Buchbinder M; Clemen MW; Fischman D; Goldberg S; Leon MB; Schatz RA; Tierstein P; Walker CM; Hirshfeld JW
    Circulation; 1992 Sep; 86(3):812-9. PubMed ID: 1516193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.